Advertisement
AYTU vs HROW
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Hold and HROW is a Hold.
AYTU's Indicator enters downward trend
The Aroon Indicator for AYTU entered a downward trend on September 25, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 304 similar instances where the Aroon Indicator formed such a pattern. In 271 of the 304 cases the stock moved lower. This puts the odds of a downward move at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AYTU as a result. In 87 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for AYTU turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 44 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
AYTU moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AYTU crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AYTU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AYTU's RSI Indicator exited the oversold zone, 34 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where AYTU advanced for three days, in 165 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
AYTU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.668) is normal, around the industry mean (43.873). P/E Ratio (0.005) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.320) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. AYTU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AYTU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
HROW's Indicator enters downward trend
The Aroon Indicator for HROW entered a downward trend on October 13, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 202 similar instances where the Aroon Indicator formed such a pattern. In 168 of the 202 cases the stock moved lower. This puts the odds of a downward move at 83%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 54 cases where HROW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
Following a +4.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where HROW advanced for three days, in 248 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
HROW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (78.125) is normal, around the industry mean (43.873). P/E Ratio (39.526) is within average values for comparable stocks, (141.710). Projected Growth (PEG Ratio) (0.270) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.627) is also within normal values, averaging (178.797).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. HROW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
AYTU | HROW | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 92 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 23 Undervalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 65 | |
SMR RATING 1..100 | 98 | 99 | |
PRICE GROWTH RATING 1..100 | 71 | 81 | |
P/E GROWTH RATING 1..100 | 54 | 8 | |
SEASONALITY SCORE 1..100 | n/a | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AYTU's Valuation (23) in the Other Consumer Services industry is somewhat better than the same rating for HROW (78) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew somewhat faster than HROW’s over the last 12 months.
HROW's Profit vs Risk Rating (65) in the Pharmaceuticals Other industry is somewhat better than the same rating for AYTU (100) in the Other Consumer Services industry. This means that HROW’s stock grew somewhat faster than AYTU’s over the last 12 months.
AYTU's SMR Rating (98) in the Other Consumer Services industry is in the same range as HROW (99) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to HROW’s over the last 12 months.
AYTU's Price Growth Rating (71) in the Other Consumer Services industry is in the same range as HROW (81) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to HROW’s over the last 12 months.
HROW's P/E Growth Rating (8) in the Pharmaceuticals Other industry is somewhat better than the same rating for AYTU (54) in the Other Consumer Services industry. This means that HROW’s stock grew somewhat faster than AYTU’s over the last 12 months.
| AYTU | HROW | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 87% | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 69% |
| Momentum ODDS (%) | 1 day ago 89% | N/A |
| MACD ODDS (%) | 1 day ago 86% | N/A |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 78% | 1 day ago 83% |
| Advances ODDS (%) | 21 days ago 73% | 23 days ago 83% |
| Declines ODDS (%) | 3 days ago 85% | 1 day ago 79% |
| BollingerBands ODDS (%) | 6 days ago 74% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AYTU’s FA Score shows that 1 FA rating(s) are green while HROW’s FA Score has 1 green FA rating(s).
- AYTU’s FA Score: 1 green, 4 red.
- HROW’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AYTU’s TA Score shows that 4 TA indicator(s) are bullish while HROW’s TA Score has 4 bullish TA indicator(s).
- AYTU’s TA Score: 4 bullish, 6 bearish.
- HROW’s TA Score: 4 bullish, 2 bearish.
Price Growth
AYTU (@Pharmaceuticals: Generic) experienced а -2.93% price change this week, while HROW (@Pharmaceuticals: Generic) price change was -6.95% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.86%. For the same industry, the average monthly price growth was -3.86%, and the average quarterly price growth was +15.65%.
Reported Earning Dates
AYTU is expected to report earnings on Nov 16, 2026.
HROW is expected to report earnings on Nov 16, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.86% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
AYTU and
Correlation & Price change
A.I.dvisor tells us that AYTU and OGI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and OGI's prices will move in lockstep.
| Ticker / NAME | Correlation To AYTU | 1D Price Change % | ||
|---|---|---|---|---|
| AYTU | 100% | +1.02% | ||
| OGI - AYTU | 27% Poorly correlated | -1.68% | ||
| ZYBT - AYTU | 27% Poorly correlated | -12.43% | ||
| IRWD - AYTU | 24% Poorly correlated | -4.52% | ||
| HROW - AYTU | 24% Poorly correlated | -2.99% | ||
| DERM - AYTU | 23% Poorly correlated | -3.89% | ||
More | ||||
HROW and
Correlation & Price change
A.I.dvisor indicates that over the last year, HROW has been loosely correlated with AQST. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then AQST could also see price increases.
| Ticker / NAME | Correlation To HROW | 1D Price Change % | ||
|---|---|---|---|---|
| HROW | 100% | -2.99% | ||
| AQST - HROW | 36% Loosely correlated | -2.91% | ||
| AMRX - HROW | 29% Poorly correlated | -2.30% | ||
| AYTU - HROW | 29% Poorly correlated | +1.02% | ||
| RMTI - HROW | 27% Poorly correlated | +3.70% | ||
| TEVA - HROW | 27% Poorly correlated | +0.19% | ||
More | ||||